IPP Bureau

Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr
Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr

By IPP Bureau - August 04, 2023

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023

Sartorius Bioreactors integrate Emerson Technology to speed new therapies to market
Sartorius Bioreactors integrate Emerson Technology to speed new therapies to market

By IPP Bureau - August 04, 2023

DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time

Supriya Lifescience collaborates with Plasma Nutrition for protein technology
Supriya Lifescience collaborates with Plasma Nutrition for protein technology

By IPP Bureau - August 03, 2023

The primary purpose of this collaboration is to bring the optimized protein into the Indian market

Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr
Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

By IPP Bureau - August 03, 2023

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023

Narayana Hrudayalaya posts Q1 FY24 consolidated PAT at Rs. 183.95 Cr
Narayana Hrudayalaya posts Q1 FY24 consolidated PAT at Rs. 183.95 Cr

By IPP Bureau - August 03, 2023

The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023

Schneider Electric commits to Ayushman Bharat with EcoStruxure
Schneider Electric commits to Ayushman Bharat with EcoStruxure

By IPP Bureau - August 03, 2023

Aims to foster a Resilient and Sustainable Healthcare Ecosystem

Medica, Kolkata and UNICEF collaborate to empower working mothers
Medica, Kolkata and UNICEF collaborate to empower working mothers

By IPP Bureau - August 03, 2023

Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop

Zydus receives USFDA's final approval for Indomethacin Suppository with competitive generic therapy designation
Zydus receives USFDA's final approval for Indomethacin Suppository with competitive generic therapy designation

By IPP Bureau - August 03, 2023

Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.

Roquette to acquire Qualicaps from Mitsubishi Chemical Group
Roquette to acquire Qualicaps from Mitsubishi Chemical Group

By IPP Bureau - August 03, 2023

Qualicaps is the third largest producer of hard capsules for oral dosage solutions

DuPont completes acquisition of Spectrum Plastics Group
DuPont completes acquisition of Spectrum Plastics Group

By IPP Bureau - August 03, 2023

With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment

Thyrocare Technologies posts Q1 FY24 PAT at Rs. 17.30 Cr
Thyrocare Technologies posts Q1 FY24 PAT at Rs. 17.30 Cr

By IPP Bureau - August 02, 2023

The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023

Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr
Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr

By IPP Bureau - August 02, 2023

The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023

Lupin receives approval from US FDA for Turqoz
Lupin receives approval from US FDA for Turqoz

By IPP Bureau - August 02, 2023

Norgestrel and Ethinyl Estradiol Tablets USP (RLD Lo/Ovral-28) had an estimated annual sale of USD 34 million in the U.S. (IQVIA MAT Mar 2023)

Syrma SGS acquires majority sake in Johari Digital Healthcare
Syrma SGS acquires majority sake in Johari Digital Healthcare

By IPP Bureau - August 02, 2023

JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices

Fredun Pharmaceuticals achieves milestone in Pet Care Division
Fredun Pharmaceuticals achieves milestone in Pet Care Division

By IPP Bureau - August 01, 2023

The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision

Latest Stories

Interviews

Packaging